225-Ac-anti-VLA-4 antibody (Johns Hopkins University School of Medicine)

N/A

Report date: 2026/01/26 17:58:54

Base Information

Drug Name225-Ac-anti-VLA-4 antibody (Johns Hopkins University School of Medicine)

Drug Alias Nameanti-VLA-4 antibody (Johns Hopkins University School of Medicine)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Nuclides > Actinium > 225AcBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) +[4]

Mechanisms of ActionIntegrin alpha-4/beta-1 antagonists

TargetsIntegrin alpha-4/beta-1

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJohns Hopkins University School Of Medicine

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJohns Hopkins University School Of Medicine

Active IndicationsN/A

Inactive IndicationsMelanoma

Other Information

ATC CodeN/A